The Design of Clinical Trials for New Molecularly Targeted Compounds: Progress and New Initiatives

By  

Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. : 2279-2284

Bentham Science Publishers

Access to resources Recommend Favorite

New Directions for Clinical Trials of Targeted Alpha Therapy for Metastatic Melanoma

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 3, 2008-09 ,pp. : 240-250

Bentham Science Publishers

Access to resources Recommend Favorite

Enhancing the Technology of Clinical Trials and the Trials Model to Evaluate Newly Developed, Targeted Antidepressants

By Katz M.M.   Halbreich U.M.   Bowden C.L.   Frazer A.   Pinder R.M.   Rush A.J.   Wheatley D.P.   Lebowitz B.D.  

Neuropsychopharmacology, Vol. 27, Iss. 3, 2002-09 ,pp. : 319-328

Elsevier

Access to resources Recommend Favorite

Missing Data and Censoring in the Analysis of Progression-Free Survival in Oncology Clinical Trials

By Denne J. S.   Stone A. M.   Bailey-Iacona R.   Chen T.-T.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 951-970

Taylor & Francis Ltd

Access to resources Recommend Favorite

Intermediate clinical endpoints: A bridge between progression-free survival and overall survival in ovarian cancer trials

By Matulonis Ursula A.   Oza Amit M.   Ho Tony W.   Ledermann Jonathan A.  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1737-1746

Blackwell Publishing

Access to resources Recommend Favorite